Results 21 to 30 of about 45,910 (249)
The Intriguing Links between Psoriasis and Bullous Pemphigoid
Journal of Clinical Medicine, 2022 The coexistence of psoriasis with autoimmune bullous diseases (AIBDs), particularly bullous pemphigoid (BP), has been documented in case reports and series, as well as in epidemiological studies. The onset of psoriasis precedes that of BP in the majority
C. Maronese +5 more
semanticscholar +1 more source
Evaluating risk of bullous pemphigoid after mRNA COVID‐19 vaccination
British Journal of Dermatology, 2022 Our results suggest mRNA COVID-19 vaccination is not associated with increased risk of new-onset bullous pemphigoid. Hopefully, health care professionals may use the findings reported herein to counsel patients experiencing vaccine hesitancy for concerns
Morgan Birabaharan +4 more
semanticscholar +1 more source
Bilateral localized bullous pemphigoid in a young adult patient: A case report
SAGE Open Medical Case Reports, 2023 Bullous pemphigoid is the most common autoimmune subepidermal blistering disease, which typically presents in the elderly. Localized bullous pemphigoid is a rare variant of bullous pemphigoid, with only about 100 cases reported up to date. In this report,
Pedram Nourmohammadpour +5 more
doaj +1 more source
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
Frontiers in Immunology, 2021 Background Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are often limited by their side effects.
Yihua Zhang +7 more
semanticscholar +1 more source
European Journal of Case Reports in Internal Medicine, 2022 Bullous pemphigoid is a rare autoimmune dermatologic disease that usually occurs in the elderly. Mucous membrane lesions occur in about 10–35% of patients and are almost always limited to the oral mucous membrane. Esophageal involvement is very rare (4% of cases) and usually presents with chest pain, dysphagia, and odynophagia, though patients are ...
Castelo Branco, Catarina +2 more
openaire +4 more sources
AUTOIMMUNE BULLOUS DERMATOSES. DIFFERENTIAL DIAGNOSIS
Vestnik Dermatologii i Venerologii, 2017 The review presents modern ideas concerning autoimmune bullous dermatoses (pemphigoid group): Duhring disease, bullous pemphigoid, cicatrizing pemphigus, pemphigoid gestationis, linear IgA bullous dermatosis and acquired bullous epidermolysis ...
V. I. Al'banova, M. A. Nefedova
doaj +1 more source
BMJ Open, 2020 Objectives The validity of bullous pemphigoid and pemphigus vulgaris recording in routinely collected healthcare data in the UK is unknown. We assessed the positive predictive value (PPV) for bullous pemphigoid and pemphigus vulgaris primary care Read ...
Yana Vinogradova +6 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 Bullous pemphigoid is an acquired autoimmune subepidermal blistering disease that can arise following exposure to systemic medication, referred to as drug-induced bullous pemphigoid.
Louise M Gresham, Mark G Kirchhof
doaj +1 more source
Frontiers in Medicine, 2018 An 83-year-old patient developed erosions and a blister of the gingival mucous membrane, 6 months after discontinuation of the anti-programmed death-1 (anti PD-1) pembrolizumab therapy administered for 10 months for a metastatic melanoma.
C. Zumelzu +10 more
semanticscholar +1 more source
Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy [PDF]
, 2017 Paraneoplastic pemphigus is a rare autoimmune skin disease that is always associated with a neoplasm. Usually, oral, skin, and mucosal lesions are the earliest manifestations shown by paraneoplastic pemphigus patients.
Andrea Ciofalo +21 more
core +4 more sources